0

524632

SHUKRAPHAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Shukra Pharmaceuticals Limited Share Price Today

Investment Returns

Over 1 Month 2.66% Over 3 Months -23.37% Over 6 Months -44.75% Over 1 Year 117.37%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Shukra Pharmaceuticals Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 1,323.30
  • P/E Ratio (TTM) 60.88
  • Beta 0.59
  • Book Value / share 2.05
  • Return on equity 15.90%
  • EPS (TTM) 0.50
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -1.73
info icon alternate text

Shukra Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 6.30
Operating Expense 6.88
Net Profit -1.73
Net Profit Margin (%) -27.46
Earnings Per Share (EPS) -0.04
EBITDA 1.64
Effective Tax Rate (%) 564.86
Particulars DEC 2025 (Values in Cr)
Revenue 39.13
Operating Expense 13.12
Net Profit 20.36
Net Profit Margin (%) 52.03
Earnings Per Share (EPS) 0.47
EBITDA 27.95
Effective Tax Rate (%) 24.11
Particulars SEP 2025 (Values in Cr)
Revenue 5.88
Operating Expense 7.40
Net Profit 2.38
Net Profit Margin (%) 40.47
Earnings Per Share (EPS) 0.05
EBITDA 1.30
Effective Tax Rate (%) -1090.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.39
Operating Expense 5.13
Net Profit 1.03
Net Profit Margin (%) 19.10
Earnings Per Share (EPS) 0.02
EBITDA 2.43
Effective Tax Rate (%) 24.81
Particulars MAR 2025 (Values in Cr)
Revenue 13.27
Operating Expense 7.16
Net Profit 5.39
Net Profit Margin (%) 40.61
Earnings Per Share (EPS) 0.12
EBITDA 8.78
Effective Tax Rate (%) 28.79
Particulars MAR 2026 (Values in Cr)
Revenue 56.71
Operating Expense 32.52
Net Profit 22.05
Net Profit Margin (%) 38.88
Earnings Per Share (EPS) 0.50
EBITDA 33.30
Effective Tax Rate (%) 23.35
Particulars MAR 2025 (Values in Cr)
Revenue 32.59
Operating Expense 23.45
Net Profit 9.58
Net Profit Margin (%) 29.39
Earnings Per Share (EPS) 0.22
EBITDA 16.93
Effective Tax Rate (%) 28.18
Particulars MAR 2024 (Values in Cr)
Revenue 74.57
Operating Expense 57.51
Net Profit 18.54
Net Profit Margin (%) 24.86
Earnings Per Share (EPS) 16.93
EBITDA 22.22
Effective Tax Rate (%) 6.79
Particulars MAR 2023 (Values in Cr)
Revenue 58.83
Operating Expense 55.59
Net Profit 4.41
Net Profit Margin (%) 7.49
Earnings Per Share (EPS) 11.23
EBITDA 6.56
Effective Tax Rate (%) 0.90
Particulars MAR 2022 (Values in Cr)
Revenue 20.49
Operating Expense 19.55
Net Profit 0.75
Net Profit Margin (%) 3.66
Earnings Per Share (EPS) 4.79
EBITDA 2.96
Effective Tax Rate (%) 26.47
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1.44
ROE % 15.90
ROCE % 21.76
Total Debt to Total Equity 0.06
EBITDA Margin 51.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 52.65
ROE % 44.71
ROCE % 44.16
Total Debt to Total Equity 0.10
EBITDA Margin 29.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 64.63
ROE % 21.18
ROCE % 18.84
Total Debt to Total Equity 0.20
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.43
ROE % 4.69
ROCE % 5.81
Total Debt to Total Equity 0.41
EBITDA Margin 14.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.63
ROE % 0.90
ROCE % 1.35
Total Debt to Total Equity 0.57
EBITDA Margin 16.07
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.11
Total Assets 86.76
Total Liabilities 86.76
Total Equity 62.83
Share Outstanding 43
Price to Book Ratio 15.17
Return on Assets (%) 11.03
Return on Capital (%) 14.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 77.83
Total Liabilities 77.83
Total Equity 57.63
Share Outstanding 1
Price to Book Ratio 6.20
Return on Assets (%) 23.81
Return on Capital (%) 30.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.97
Total Assets 74.96
Total Liabilities 74.96
Total Equity 25.29
Share Outstanding 0
Price to Book Ratio 0.73
Return on Assets (%) 5.87
Return on Capital (%) 14.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 35.11
Total Liabilities 35.11
Total Equity 16.35
Share Outstanding 0
Price to Book Ratio 0.58
Return on Assets (%) 2.13
Return on Capital (%) 3.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 35.60
Total Liabilities 35.60
Total Equity 15.59
Share Outstanding 0
Price to Book Ratio 0.45
Return on Assets (%) 0.52
Return on Capital (%) 0.74
Particulars MAR 2025 (Values in Cr)
Net Income 13.33
Cash from Operations 11.67
Cash from Investing -1.26
Cash from Financing -4.51
Net change in Cash 2.13
Free Cash Flow 14.42
Particulars MAR 2024 (Values in Cr)
Net Income 19.88
Cash from Operations -4.57
Cash from Investing -1.20
Cash from Financing 12.40
Net change in Cash 6.00
Free Cash Flow -2.81
Particulars MAR 2023 (Values in Cr)
Net Income 4.44
Cash from Operations 3.41
Cash from Investing -4.42
Cash from Financing 4.94
Net change in Cash 3.68
Free Cash Flow 7.91
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 8.42
Cash from Investing -1.52
Cash from Financing -6.67
Net change in Cash -0.21
Free Cash Flow 9.97
Particulars MAR 2021 (Values in Cr)
Net Income 0.09
Cash from Operations 0.53
Cash from Investing -1.89
Cash from Financing 1.73
Net change in Cash 0.37
Free Cash Flow 2.32
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 13.36 1.56 247.83 23.12 38.85
BLISS GVS PHARMA LTD. 453.35 36.80 4.03 4808.06 118.35 462.70
CIPLA LTD 1372.75 29.13 3.22 110896.97 1165.55 1672.20
FERMENTA BIOTECH LIMITED 320.60 14.14 2.32 943.56 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 22.62 4.16 247.83 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 544.35 24.40 4.25 1573.75 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8499.70 111.01 24.34 21249.25 7630.00 10557.00
BLISS GVS PHARMA LTD. 453.35 48.91 4.16 4808.06 118.35 462.70

Shukra Pharmaceuticals Limited shareholding pattern

Holding
48.92%
50.95%
0.11%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Shukra Pharmaceuticals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
30.22 -0.72 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 30.70
  • 26 Days 30.60
  • 10 Days 30.50
  • 50 Days 31.90
  • 12 Days 30.50
  • 100 Days 34.30
  • 20 Days 30.40
  • 200 Days 33.80
31.09 PIVOT
First Support 30.57 First Resistance 31.67 Second Support 29.99 Second Resistance 32.19 Third Support 29.47 Third Resistance 32.77
RSI 52.41 ADX 25.49 MACD -0.21 Williams % R -39.68 Commodity Channel Index (CCI) 91.96
Date 2026-06-16 Week 133739.00 Same Day 93428.00 Month 190698.00
1 Year 0.60 3 Year 0.25
Over 1 Month
2.66% down
Over 1 Year
117.37% down
Over 3 Months
-23.37% down
Over 3 Years
87.04% down
Over 6 Months
-44.75% down
Over 5 Years
149.83% down

Shukra Pharmaceuticals Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 0.01 Final 18 Sep 2025 Equity shares
23 Sep 2024 1.0 Final 24 Sep 2024 Equity shares
15 Sep 2023 0.5 Final 16 Sep 2023 Equity shares
22 Sep 2022 0.5 Final 22 Sep 2022 Equity shares
19 Sep 2019 0.5 Final 21 Sep 2019 Equity shares
31 Aug 2018 0.5 Final 04 Sep 2018 Equity shares
01 Sep 2017 0.5 Final 05 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
20 Apr 2024 19 Apr 2024 3:1
Ex-Date Old FV NEW FV Record Date
21 Mar 2025 10.0 1.0 21 Mar 2025

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shukra Pharmaceuticals Ltd?

Answer Field

Shukra Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 30.22 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Shukra Pharmaceuticals Ltd Share?

Answer Field

The market cap of Shukra Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 1,323.30 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 65.26 and ₹ 12.97.

What is 1 year return for Shukra Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 121.06%.

What is the P/E Ratio of Shukra Pharmaceuticals Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Shukra Pharmaceuticals Ltd share is 60.88.

What is the PB ratio of Shukra Pharmaceuticals Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Shukra Pharmaceuticals Ltd share is 2.05.

How to Buy Shukra Pharmaceuticals Ltd Share?

Answer Field

You can trade in Shukra Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shukra Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Shukra Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shukra Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|